Project 4 - Image-guided and model-based dosimetry for optimal PDT Project 4 focuses on novel technologies and tools for advancing the ability to image PDT dose or response to therapy at the levels of structural, functional and molecular interactions. The design is specifically on testing new approaches which link to the two clinical trial projects in skin and pancreas tumors.
In aim 1, the range of technologies to quantify protoporphyrin IX (PpIX) in skin and the biophysical measures of blood flow, blood volume, oxygen saturation and collagen, are measured alongside high frequency US imaging. The focus is to establish a set of tools which allow intelligent combinations of enhancers to PpIX production in squamous cell and basal cell carcinoma, as being treated in Project 1.
Aims 2 and 3 both focus on pancreas cancer (PanCa) working with Project 2, with an initial focus on using contrast-CT and US to track total blood volume in the tumors, prior to light therapy and in the response to treatment. Preliminary Phase 1 clinical data indicates that total blood volume, as estimated from contrast-CT, is the dominant dosimetric parameter which predicts lesion volume in the response, suggesting that PS measurement is less important than light dosimetry for this particular indication. This observation is followed up in a systematic series of studies in a large animal orthotopic tumor model in the rabbit pancreas, as a way to better simulate the clinical trial data using contrast CT.
Aim 3 further develops our work on molecular imaging and the quantification of binding in vivo with project 3. Using a dual-tracer approach developed in the current funding period, we analyze the efficiency of binding-directed uptake of targeted nanocells, from in an orthotopic PanCa model. This quantification importantly allows separation of vascular leakage and interstitial transport from the more important information of binding and uptake in the cancer cells. We will test methods to improve interstitial transport and determine if the nanoconstructs are limited by binding or delivery in PanCa. In the end, this series of aims is both basic technology and methodology design and optimization with direct potential to translate into clinical trial use. It is our expectation that the results will be directly translate to impact the clinical trials within this proposed funding period, with technology transfer occurring through Core C to each of the other projects.

Public Health Relevance

TO PUBLIC HEALTH Project 4 develops novel tools and techniques which will directly advance the ability to monitor treatment at the individual subject level. The resulting approaches can be used in humans during PDT treatment to plan dose delivery or monitor treatment to either better understand variation in response or to alter therapy to minimize the variation in response. Dosimetry planning and imaging, when done well, will improve therapeutic delivery.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA084203-13
Application #
9213353
Study Section
Special Emphasis Panel (ZCA1)
Project Start
2001-08-09
Project End
Budget Start
2017-01-01
Budget End
2017-12-31
Support Year
13
Fiscal Year
2017
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02114
Pereira, S P; Goodchild, G; Webster, G J M (2018) The endoscopist and malignant and non-malignant biliary obstruction. Biochim Biophys Acta Mol Basis Dis 1864:1478-1483
Broekgaarden, Mans; Rizvi, Imran; Bulin, Anne-Laure et al. (2018) Neoadjuvant photodynamic therapy augments immediate and prolonged oxaliplatin efficacy in metastatic pancreatic cancer organoids. Oncotarget 9:13009-13022
Huang, Huang-Chiao; Rizvi, Imran; Liu, Joyce et al. (2018) Photodynamic Priming Mitigates Chemotherapeutic Selection Pressures and Improves Drug Delivery. Cancer Res 78:558-571
Huang, Huang-Chiao; Pigula, Michael; Fang, Yanyan et al. (2018) Immobilization of Photo-Immunoconjugates on Nanoparticles Leads to Enhanced Light-Activated Biological Effects. Small :e1800236
Wang, Hexuan; Mislati, Reem; Ahmed, Rifat et al. (2018) Elastography can map the local inverse relationship between shear modulus and drug delivery within the pancreatic ductal adenocarcinoma microenvironment. Clin Cancer Res :
Obaid, Girgis; Jin, Wendong; Bano, Shazia et al. (2018) Nanolipid Formulations of Benzoporphyrin Derivative: Exploring the Dependence of Nanoconstruct Photophysics and Photochemistry on Their Therapeutic Index in Ovarian Cancer Cells. Photochem Photobiol :
Marra, Kayla; LaRochelle, Ethan P; Chapman, M Shane et al. (2018) Comparison of Blue and White Lamp Light with Sunlight for Daylight-Mediated, 5-ALA Photodynamic Therapy, in vivo. Photochem Photobiol 94:1049-1057
Pereira, Stephen P; Jitlal, Mark; Duggan, Marian et al. (2018) PHOTOSTENT-02: porfimer sodium photodynamic therapy plus stenting versus stenting alone in patients with locally advanced or metastatic biliary tract cancer. ESMO Open 3:e000379
Maytin, Edward V; Kaw, Urvashi; Ilyas, Muneeb et al. (2018) Blue light versus red light for photodynamic therapy of basal cell carcinoma in patients with Gorlin syndrome: A bilaterally controlled comparison study. Photodiagnosis Photodyn Ther 22:7-13
Lee, Han Hee; Choi, Myung-Gyu; Hasan, Tayyaba (2017) Application of photodynamic therapy in gastrointestinal disorders: an outdated or re-emerging technique? Korean J Intern Med 32:1-10

Showing the most recent 10 out of 173 publications